Micro-g environment

Alain Berinstain Joins CSS as Chief Strategy Officer

Retrieved on: 
Thursday, February 15, 2024
White House, Federal Government, Public Policy, Government, Aerospace, Manufacturing, Other Science, Research, Science, Doctor of Philosophy, Multimedia, IMEWG, Micro-g environment, Growth, International Space University, Alain, Moon Express, Physical organic chemistry, Biochemistry, History, Master, Mir, Space Shuttle, International Space Station, CSO, CSS, Management

CSS Inc, www.css-inc.com , an employee-owned, science-based solutions company serving both government and commercial customers, announces today the appointment of Dr. Alain Berinstain as its Chief Strategy Officer (CSO), effective February 12, 2024.

Key Points: 
  • CSS Inc, www.css-inc.com , an employee-owned, science-based solutions company serving both government and commercial customers, announces today the appointment of Dr. Alain Berinstain as its Chief Strategy Officer (CSO), effective February 12, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240215083518/en/
    Berinstain joins the executive team at CSS, reporting to the CEO and co-founder, Dennis Lauchner.
  • When making the announcement, Lauchner said, “Alain is a veteran of the space industry with experience in both the public and private sectors.
  • I am so fortunate to be able to leverage CSS’ 35 years of credibility and capabilities to combine them with my experience and network.

In-Space Manufacturing Leader Space Forge Appoints New Director of Strategy and Innovation

Retrieved on: 
Wednesday, November 8, 2023
Science, Education, Innovation, Micro-g environment, Zero Gravity Corporation, Non-U.S. operators of the M60 Patton, Research, Space Forge, Alloy, Spacecraft, NASA, Semiconductor, FAA, Management

WASHINGTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Space Forge, the UK-based leader for in-space manufacturing, announced today a significant addition to its U.S. leadership team with the appointment of Michelle Flemming as Director of Strategy and Innovation.

Key Points: 
  • WASHINGTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Space Forge, the UK-based leader for in-space manufacturing, announced today a significant addition to its U.S. leadership team with the appointment of Michelle Flemming as Director of Strategy and Innovation.
  • The company has been rapidly expanding its global footprint and in June announced industry leader Andrew Parlock as Director of U.S. Operations.
  • Having participated in over 250 parabolic flight missions, her hands-on understanding of microgravity environments provides Space Forge with a unique advantage for its in-space manufacturing initiatives.
  • For more information about Space Forge and its mission, please visit Space Forge's official website.

From Seattle to Space: Science that Began at the Allen Institute Blasts off to International Space Station

Retrieved on: 
Thursday, May 18, 2023
Immortalised cell line, DNA, Partnership, Cancer Institute, Scientific research on the International Space Station, Axiom Space, Cell, Cell proliferation, Biomedical Research, Research, Disease, Biomedical sciences, Transfection, Allen Institute for Cell Science, Allen Institute, Cell potency, NASA, Collection, Micro-g environment, Organelle, B cell, Health, Vaccine, Medical imaging, Cedars-Sinai Medical Center

SEATTLE, May 18, 2023 /PRNewswire/ --This Sunday (May 21) at 2:37 p.m. PDT1, astronauts from Axiom Space in partnership with Cedars-Sinai will blast off to the International Space Station carrying cells from the Allen Institute for Cell Science, a division of the Allen Institute. There, Axiom Space astronauts will perform experiments and send real-time data back to researchers at Cedars-Sinai as part of their study on the effects of microgravity on human cells.

Key Points: 
  • For the first time astronauts will transport Allen Institute cells into space where Cedars-Sinai researchers will study the effects of microgravity.
  • SEATTLE, May 18, 2023 /PRNewswire/ --This Sunday (May 21) at 2:37 p.m. PDT1, astronauts from Axiom Space in partnership with Cedars-Sinai will blast off to the International Space Station carrying cells from the Allen Institute for Cell Science , a division of the Allen Institute.
  • The experiments are part of the Ax-2 mission , funded by NASA and Axiom Space, and represent a major milestone: It will be the first time Allen Institute-generated cells are flown to space.
  • These cells are part of the publicly available Allen Cell Collection , a suite of human induced pluripotent stem cells gene-edited to illuminate different parts of the cell.

RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station

Retrieved on: 
Friday, December 9, 2022
Science, Health, Research, Medical Devices, Faculty, Periodontology, Journal of Indian Society of Pedodontics and Preventive Dentistry, National Institute of Dental and Craniofacial Research, Commercial Resupply Services, McGowan Institute for Regenerative Medicine, Doctor of Philosophy, ISS National Lab, ISS, SpaceX, Patient, National Institute on Aging, Research, Scientific research on the International Space Station, SpaceX CRS-26, CASIS, International Space Station, Bone, Histology, Condition, Tomography, University, Boeing, Multimedia, Regenerative medicine, MassChallenge, ISSNL, Osteoporosis, Micro-g environment, National Institute of Neurological Disorders and Stroke, DDS, Associate, Pharmaceutical industry, Science, Stroke

RevBio, Inc., announced that an experiment to study Tetranite, the companys regenerative bone adhesive biomaterial, has successfully been initiated onboard the International Space Station (ISS).

Key Points: 
  • RevBio, Inc., announced that an experiment to study Tetranite, the companys regenerative bone adhesive biomaterial, has successfully been initiated onboard the International Space Station (ISS).
  • On Saturday, November 26, 2022, the study materials were launched to the space station on SpaceXs 26th Commercial Resupply Services (SpaceX CRS-26) mission , sponsored by the ISS National Laboratory.
  • View the full release here: https://www.businesswire.com/news/home/20221201005635/en/
    RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station.
  • Dr. Intini and RevBio are expected to publish the complete results of the experiment by the end of next year.

NSF and CASIS Join Forces to Solicit Research Utilizing the International Space Station

Retrieved on: 
Thursday, December 8, 2022
Knowledge, Water, SPACE, Osteoblast, Tissue engineering, Atmosphere, University, Government, University of California, San Diego, Protein, Drug discovery, ISS National Lab, Partnership, ISS, Patient, Soil, Research, United States national laboratories, Scientific research on the International Space Station, CASIS, NSF, International Space Station, Wildfire, Osteoporosis, Micro-g environment, Pharmaceutical industry, Science

Knowledge gained from fundamental science studies in space could have profound impacts on future research and technology development that brings value to humanity.

Key Points: 
  • Knowledge gained from fundamental science studies in space could have profound impacts on future research and technology development that brings value to humanity.
  • In the first joint solicitation, CASIS and NSF seek projects that use the ISS National Lab to advance tissue engineering and mechanobiology research .
  • This solicitation, the sixth between CASIS and NSF focused on tissue engineering, is aimed at furthering drug discovery and therapeutic development through space-based research.
  • To learn more about previous ISS National Lab and NSF research collaborations and additional opportunities to leverage the space station, please visit www.ISSNationalLab.org .

New Publication from Exosome Diagnostics Demonstrates Proof-of-Concept for Monitoring Astronaut Health in Space

Retrieved on: 
Tuesday, October 18, 2022
KBR, Khodor Alaywan, Astronaut, Disease, Exosome, Intracranial pressure, Workflow, NASA, NASDAQ, Urine, RNA, Research, Cell, SANS, Technology, Precision medicine, Severe cognitive impairment, Diagnosis, Health, Cerebrospinal fluid, Blood, Scientific research on the International Space Station, Micro-g environment, Bio-Techne, Syndrome, Protein, Radiation, International Space Station, Baylor College of Medicine, Medical imaging, Nature

MINNEAPOLIS, Oct. 18, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has reported results from a proof-of-concept study for a novel exosome-based platform that could monitor key biological changes in astronauts in space. The peer-reviewed publication was issued in npj Microgravity, a Nature publication.

Key Points: 
  • The peer-reviewed publication was issued in npj Microgravity, a Nature publication.
  • Astronauts who return from microgravity environments in space often suffer from vision impairment, intracranial pressure, and other health problems that are not well understood.
  • "Exosome Diagnostics has spent years developing and optimizing a platform for whole-transcriptome profiling based on exosome isolation and analysis.
  • Exosome based analysis for Space Associated Neuro-Ocular Syndrome and health risks in space exploration.

Improved Pharma presenting at AAPS 2022 PHARMASCI 360 with Rapid Fire Presentation and Posters

Retrieved on: 
Tuesday, September 27, 2022
Micro-g environment, Synchrotron, SXRD, SSCI, Tablet, Payload, XRD, Lenticular Reentry Vehicle, Crystallization, COO, Ritonavir, Raman, WEST, III, Rapid Fire, AAPS, California Green Chemistry Initiative, Consultant, AB, Research, Complex, Pharmaceutical industry, Fine chemical

WEST LAFAYETTE, Ind., Sept. 27, 2022 /PRNewswire-PRWeb/ -- Improved Pharma is presenting their research on all three days of the AAPS conference. On Monday October 17th at 2:30 pm, please visit monitor #31 in forum 6. Ms. Ruba Alajlouni will present "Feasibility of Synchrotron XRD for the analysis of mixture sub-samples." She will share results demonstrating the effective utilization of synchrotron XRD (SXRD) for the analysis of mixtures.

Key Points: 
  • WEST LAFAYETTE, Ind., Sept. 27, 2022 /PRNewswire-PRWeb/ -- Improved Pharma is presenting their research on all three days of the AAPS conference .
  • On Tuesday, Improved Pharma has two posters presented concurrently at 2:30 pm in forum 8 (monitor numbers 45 and 46).
  • Dr. Susan-Bogdanowich-Knipp, President of Ravine Pharmaceuticals and Consultant with Improved Pharma, will present "Green Chemistry Initiative for Formulating, Pressing and Evaluating Tablets in Low-Resource Settings."
  • Improved Pharma is also designing and testing hardware that will provide antisolvent crystallization and evaporation capabilities in microgravity.

0-G Launch and SpaceLand Announce Signed Partnership for International Zero-Gravity Flight Services in Switzerland, Italy, and Mauritius

Retrieved on: 
Tuesday, September 20, 2022
Zero, Micro-g environment, U.N, Engineering, Center, Edu, Mir, Nobel Prize, ISS, Speech, Weightlessness, Economics, Partnership, Excellent, Person, Head, Boeing, State, Rita Levi-Montalcini, STEM, Founder, IAF, NASA, ESA, Nobel Prize controversies, Multimedia, Pathfinder, Medicine, IAC, International Astronautical Congress, Airline, Spaceland, Mars, Launch

PARIS, Sept. 20, 2022 /PRNewswire/ -- 0-G Launch, a Washington DC-based provider of the innovative Space Jet™ horizontal rocket air-launch and high-precision microgravity services aircraft, and SpaceLand™, the 1st non-governmental weightless R&D agency offering space-related educational and training programs, as well as engineering & operational support through its "Centers of Excellence for Microgravity," today announced their signed agreement to initiate exclusive zero-gravity parabolic flights from Switzerland, Italy, and Mauritius serving STEM user communities and tourists in respective continents, at unprecedented quality vs. cost ratios.

Key Points: 
  • As first part of this exclusive agreement, 0-G Launch plans to fly its specially-modified Boeing 757 Space Jet to SpaceLand training centers to provide 0-G parabolic flight experiences to consumers and researchers on a yearly recurring basis.
  • SpaceLand will organize all ground-based programs, training and facilities, and 0-G Launch will provide all aircraft-based flight operations.
  • "Our game-changing Centers of Excellence in holistic-lifestyle sites will satisfy strong market demand for low-cost access to microgravity.
  • SpaceLand Africa is the only IAF member in the Indian Ocean, expanding the legacy of the Swiss-Italian engineering group SpaceLand.

NASA, SpaceX Launch Climate Science Research, More to Space Station

Retrieved on: 
Friday, July 15, 2022
Spacecraft, Artemis, Soil, Biology, EDT, Scientific research on the International Space Station, CubeSat, Television, Nutrient, Outline of physical science, International Space Station, Ageing, Travel, Micro-g environment, NASA, Science, Jet Propulsion Laboratory, Dust, Cell, Kennedy, Atmosphere, Gene, Vaccine, Multimedia, EMIT, Carbon, Medicine, Dragon, Snow, Falcon, Education, Galveston National Laboratory, SpaceX Dragon, Kennedy Space Center, Biotechnology, ISS National Lab, 3D, Research, Environmental monitoring, NASA TV, SpaceX, Weather, Technology, Communications satellite, Mars, Moon, Immunosenescence

The spacecraft launched on a Falcon 9 rocket from Launch Pad 39A at Kennedy for the company's 25th commercial resupply services mission for NASA.

Key Points: 
  • The spacecraft launched on a Falcon 9 rocket from Launch Pad 39A at Kennedy for the company's 25th commercial resupply services mission for NASA.
  • It is scheduled to autonomously dock at the space station about 11:20 a.m. Saturday, July 16, and remain there for about a month.
  • Mineral dust blown into the air can travel significant distances and affectEarth's climate, weather, vegetation, and more.
  • BeaverCube is an education mission that will teach high school students aerospace science by having them design a CubeSat.

SpaceX CRS-24 Launching Multiple Life Science Investigations to the International Space Station

Retrieved on: 
Thursday, December 16, 2021
ISS, Regenerative medicine, Neuroinflammation, ISS National Lab, Research, Bacteria, SpaceX, Cell, PPMS, Homeostasis, Inflammation, Center, National, Plastic, National Center for Research Resources, Emulate, National Center for Advancing Translational Sciences, Patient, Center for the Advancement of Science in Space, Quality of life, Tissue, DNA, NASA, Gas, Disease, International Space Station, Micro-g environment, Gene expression, Neurodegeneration, Synthetic biology, CRS, GLOBE, Traffic barrier, PD, Commercial Resupply Services, EST, Lawrence Berkeley National Laboratory, Physiology, Technology, Scientific research on the International Space Station, Communications satellite, Vaccine, Science

SpaceXs 24th Commercial Resupply Services (CRS) mission to the orbiting laboratory will deliver a variety of life science payloads sponsored by the ISS National Laboratory (managed by the Center for the Advancement of Science in Space).

Key Points: 
  • SpaceXs 24th Commercial Resupply Services (CRS) mission to the orbiting laboratory will deliver a variety of life science payloads sponsored by the ISS National Laboratory (managed by the Center for the Advancement of Science in Space).
  • Research leveraging these effects can drive advances in pharmaceutical development, disease modeling, regenerative medicine, and many other areas within the life sciences.
  • Below are highlights of several life sciences investigations sponsored by the ISS National Laboratory that are launching on SpaceX CRS-24.
  • These are only a few of the ISS National Lab-sponsored investigations launching on SpaceX CRS-24.